LONDON (Reuters) - HMD Global, the maker of Nokia-branded smartphones, has secured $230 million of investment from partners including Google ( GOOGL.O ), Qualcomm ( QCOM.O ) and Nokia Technologies ( NOKIA.HE ), to help accelerate its development of 5G devices.

Chief Executive Florian Seiche said the success of the funding round - the largest since the Finland-based company was founded in late-2016 - validated its strategy of working closely with partners in software

(Reuters) - SiFive Inc, a California startup working to commercialize an open-source semiconductor technology, said on Tuesday that it has raised an additional $60 million in funding from investors including SK Hynix ( 000660.KS ) and Saudi Aramco.

The company said its existing investors - including venture capital arms from Intel Corp ( INTC.O ), Qualcomm Inc ( QCOM.O ) and Western Digital Corp ( WDC.O ) - also joined the funding round, bringing its total

(Reuters) - Electric vehicle startup Lucid Motors, which aims to begin selling its first luxury model, the Lucid Air, in early 2021, said on Tuesday that the new sedan is the first to achieve a 500-mile driving range.

The Lucid Air has an estimated range of 517 miles (832 km), as verified in independent testing, Lucid said.

Lucid Chief Executive Peter Rawlinson told Reuters the Air initially will be priced “well north of” $1

OAKLAND, Calif. (Reuters) - Alphabet Inc’s Google’s Android phones on Tuesday started detecting earthquakes around the world to provide data that could eventually give billions of users precious seconds of warning of a tremor nearby, with an alerting feature first rolling out in California.

MEXICO CITY (Reuters) - Mexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.

Mexico has signed memorandums of understanding with Johnson & Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at news conference.

Ebrard said the trials would start between September and January, depending on approval

LONDON (Reuters) - An announcement by Russia on Tuesday that it will approve a COVID-19 vaccine after less than two months of human testing prompted alarm among global health experts, who said that with no full trial data, the vaccine is hard to trust.

Intent on being first in the global race to develop a vaccine against the pandemic disease, Russia has yet to conduct large-scale trials of the shot that would produce data to show whether it works - something immunologists and infectious disease experts say could be

WASHINGTON (Reuters) - U.S. President Donald Trump on Tuesday said his relationship with Chinese President Xi Jinping has frayed in the wake of the novel coronavirus pandemic and that he has not spoken to his Chinese counterpart in a long time.

(Reuters) - Arcturus Therapeutics Holdings Inc said on Tuesday the first group of participants had been dosed in an early-stage trial testing its COVID-19 vaccine candidate and that results from the trial were expected in the fourth quarter.

Shares of the San Diego, California-based company rose about 4% in trading before the bell.

The company is among several drugmakers racing to develop a safe and effective vaccine for the new coronavirus that has killed more than 735,000​ people globally.